Literature DB >> 26818653

Association between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and hypertension.

Monique Tremblay1,2, Diane Brisson1,2, Daniel Gaudet1,2.   

Abstract

Despite the numerous common pathways connecting blood pressure regulation to somatostatin (SST) metabolism, the SST gene has never been seen as a significant blood pressure modulator. The aim of this study was to evaluate the association between a poly-T repeat sequence (rs34872250) in the promoter of the SST gene and blood pressure, according to the obesity status. We genotyped 1918 French-Canadian subjects from a founder population. Analyses were performed according to the length of the poly-T repeat sequence on both alleles and divided into two groups, the 13/13-13/14 group and the 13/15-13/16 group. The effect of age, gender, body mass index, antihypertensive drugs and diabetic status were considered. Systolic, diastolic and mean blood pressures are significantly higher among the 13/15-13/16 group in the whole sample (P<0.05). Whereas the differences remain significant in women, they turn to be non-significant when men are considered alone. The risk of hypertension is increased in the 13/15-13/16 group, particularly among overweight/obese subjects. Systolic blood pressure is significantly higher among overweight/obese carriers of the 13/15-13/16 alleles in the whole sample (P<0.001), in men (P=0.006) and in women (P=0.002), even after correction for age and antihypertensive drugs. These results suggest that the poly-T repeat sequence polymorphism in the promoter of the SST gene is associated with significant variations of blood pressure and could modulate the risk of hypertension, particularly among women.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26818653     DOI: 10.1038/hr.2016.4

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  48 in total

1.  Procedure to protect confidentiality of familial data in community genetics and genomic research.

Authors:  D Gaudet; S Arsenault; C Bélanger; T Hudson; P Perron; M Bernard; P Hamet
Journal:  Clin Genet       Date:  1999-04       Impact factor: 4.438

Review 2.  Candidate-gene approaches for studying complex genetic traits: practical considerations.

Authors:  Holly K Tabor; Neil J Risch; Richard M Myers
Journal:  Nat Rev Genet       Date:  2002-05       Impact factor: 53.242

3.  Meta-analysis: vasoactive medications for the management of acute variceal bleeds.

Authors:  M Wells; N Chande; P Adams; M Beaton; M Levstik; E Boyce; M Mrkobrada
Journal:  Aliment Pharmacol Ther       Date:  2012-04-08       Impact factor: 8.171

Review 4.  The evolutionary significance of cis-regulatory mutations.

Authors:  Gregory A Wray
Journal:  Nat Rev Genet       Date:  2007-03       Impact factor: 53.242

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study.

Authors:  K Miura; A R Dyer; P Greenland; M L Daviglus; M Hill; K Liu; D B Garside; J Stamler
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

7.  Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome.

Authors:  R D Murray; G E Wieringa; C A Lissett; K H Darzy; L E Smethurst; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  2002-04       Impact factor: 3.478

Review 8.  Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis.

Authors:  Patrick Maison; Anne-Isabelle Tropeano; Isabelle Macquin-Mavier; Andrea Giustina; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2007-02-20       Impact factor: 5.958

9.  Octreotide: a therapeutic option for idiopathic intracranial hypertension.

Authors:  G N Panagopoulos; S N Deftereos; G A Tagaris; M Gryllia; T Kounadi; O Karamani; D Panagiotidis; E Koutiola-Pappa; C E Karageorgiou; G Piadites
Journal:  Neurol Neurophysiol Neurosci       Date:  2007-07-10

10.  Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-24       Impact factor: 4.310

View more
  4 in total

Review 1.  "Big Data" Approaches for Prevention of the Metabolic Syndrome.

Authors:  Xinping Jiang; Zhang Yang; Shuai Wang; Shuanglin Deng
Journal:  Front Genet       Date:  2022-04-27       Impact factor: 4.772

2.  Association study between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and metabolic syndrome.

Authors:  Monique Tremblay; Diane Brisson; Daniel Gaudet
Journal:  BMC Med Genet       Date:  2018-07-27       Impact factor: 2.103

3.  Screening and identification of potential biomarkers for obstructive sleep apnea via microarray analysis.

Authors:  Yuanyuan Cao; Xintian Cai; Qing Zhu; Nanfang Li
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

Review 4.  Regulatory Mechanisms of Somatostatin Expression.

Authors:  Emmanuel Ampofo; Lisa Nalbach; Michael D Menger; Matthias W Laschke
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.